No Significant Reduction in Miscarriage Rates from NIPT Pre-Screening for Trisomy 21 as compared to invasive testing
A recent paper published by Malan et al in the Journal of the American Medical Association (JAMA) describes a clinical study conducted over two years
BRCA1 variants may generally be divided into three categories: benign variants, which cause no clinical concern; deleterious variants, which are associated with high risk of
A recent publication in Nature highlights recent research by a collaborative team from Karolinska Institute, Stockholm, and Harvard Medical School, Boston. To understand the function
Two new studies attempting to define the genetic landscape of individuals who later develop Acute Myeloid Leukemia (AML) were recently published in Nature and Nature
The team at Devyser were excited to see our products put to use in a recent research project, affirming its application in both research and
Ask Us a Question
We are specialists when it comes to diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases. Our products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in a wide array of genetic tests. Routine diagnostic laboratories in more than 50 countries worldwide use our products.